Related Experiment Video
Updated: May 9, 2026
05:56
A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
Published on: May 12, 2023
Qingfei Xiaoyan Wan alleviates asthma through multi-target network regulation
Zhenying Zhao1, Yingbo Miao, Pengwei Pan
1College of Pharmacy, Nankai University, Tianjin, People's Republic of China.
BMC Complementary and Alternative Medicine
|August 8, 2013
Summary
Qingfei Xiaoyan Wan (QFXY) demonstrates anti-inflammatory and anti-remodeling effects in an asthma model. This traditional Chinese medicine works through a multi-target network, influencing gene and protein expression for asthma control.
Area of Science:
- Pharmacology
- Traditional Chinese Medicine
- Systems Biology
Background:
- Qingfei Xiaoyan Wan (QFXY) is a traditional Chinese formula used for respiratory conditions like asthma.
- While effective and well-tolerated, QFXY's precise mechanism of action as an asthma controller remains unclear.
- This study aimed to elucidate the multi-target network regulation of QFXY in asthma.
Purpose of the Study:
- To investigate the molecular mechanisms underlying the therapeutic effects of QFXY in an experimental asthma model.
- To identify key genes and proteins regulated by QFXY in asthma.
- To construct a target regulation network for QFXY in asthma treatment.
Main Methods:
- An asthma model was induced in guinea pigs using histamine and acetylcholine.
- QFXY was administered orally, and its effects were evaluated using Hematoxylin-Eosin staining.
- Differential gene and protein expression were analyzed using microarrays, 2D electrophoresis, and mass spectrometry.
- Bioinformatic analyses (Cluster, GO, KEGG) and network construction were performed using GAD and HPRD databases.
Main Results:
- The established asthma model showed anti-inflammatory and anti-remodeling effects upon QFXY treatment.
- Compared to the model group, 55 differentially expressed genes and 6 differentially expressed proteins were identified in the QFXY-treated group.
- Quantitative PCR and Western blot validated the microarray and 2D electrophoresis data.
- A comprehensive QFXY-asthma target regulation network was successfully constructed.
Conclusions:
- Combined genomic and proteomic analyses identified candidate genes and proteins modulated by QFXY.
- QFXY's therapeutic effect in asthma is attributed to a combined mechanism involving anti-inflammation and anti-remodeling.
- QFXY influences signal transduction pathways in vivo, contributing to its efficacy as an asthma controller.
Related Concept Videos
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:30Asthma-IV: Nursing Management
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...